Beyond auscultation - Acoustic cardiography in the diagnosis and assessment of cardiac disease

Swiss Medical Weekly

Volumn 138, Issue 31-32, 2008, Pages 439-452

  Erne, Paul ^a,b  

^a Division of Cardiology Kantonsspital Luzern   (Switzerland)

^b LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Cardiovascular diagnosis; Electrocardiogram; Heart sounds

Indexed keywords

CARDIOVASCULAR AGENT;

ACOUSTICS; ALGORITHM; AUSCULTATION; CARDIOGRAPHY; COMPUTER AIDED DESIGN; COST EFFECTIVENESS ANALYSIS; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART SOUND; HUMAN; INTERMETHOD COMPARISON; PACEMAKER; PHONOCARDIOGRAPHY; REVIEW; SLEEP APNEA SYNDROME; TECHNOLOGY;

EID: 49549118236     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Morris JS. Laennec's stethoscope - the Welsh connection. R Soc Med. 2004;97:137-41.
2. Potain P. Adherence du pericarde: triple bruit du coeur; implusion diastolique. Bull Soc Anat Paris. 1856;31:378.
3. Potain P. Concerning the cardiac rhythm called gallop rhythm (Fr). Bull Soc Med Hop Paris. 1876;12:137-66.
4. Pierre-Carl Potain (1825-1901) cardiovascular physician. JAMA. 1966;196:1086.
5. Rame JE, Dries DL, Drazner MH. The prognostic value of the physical examination in patients with chronic heart failure. Congest Heart Fail. 2003;9:170-5, 178.
6. Reddy PS. The third heart sound. Im J Cardiol. 1985;7(3):213-21.
7. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261(6):884-8.
8. Sloan A. Cardiac gallop rhythm. Medicine. 1958;37:197-215.
9. Drazner MH, Rame JE, Stevenson LW, Dries DL. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med. 2001;345:574-81.
10. Drazner MH, Rame JE, Dries DL. Third heart sound and elevated jugular pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction. Am J Med. 2003;114:431-7.
11. Shah PM, Gramiak R, Kramer DH, Yu PN. Determinants of atrial (S4) and ventricular (S3) gallop sounds in primary myocardial disease. N Engl J Med. 1968;278(4):753-8.
12. Glower DD, Murah RL, Olsen CO, Rankin JS. Mechanical correlates of the third heart sound. J Am Coll Cardiol. 1992;19(2):450-7.
13. Kono T, Rosman H, Alam M, Stein PD, Sabbah HN. Haemodynamic correlates of the third heart sound during the evolution of chronic heart failure. J Am Coll Cardiol. 1993;21(2):419-23.
14. Tribouilloy CM, Enriquez-Sarano M, Mohty D, Horn RA, Bailey KR, Seward JB, et al. Pathophysiologic determinants of third heart sounds: a prospective clinical and Doppler echocardiographic study. Am J Med. 2001;111(2):96-112.
15. Ozawa Y, Smith D, Craige E. Origin of the third heart sound. II. Studies in human subjects. Circulation. 1983;67(2):399-404.
16. Ishmail AA, Wing S, Ferguson J, Hutchinson TA, Magder S, Flegel KM. Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. Chest. 1987;91:870-3.
17. Lok CE, Morgan CD, Ranganathan N. The accuracy and interobserver agreement in detecting the "gallop sounds" by cardiac auscultation. Chest. 1998;114:1281-8.
18. Davie AP, Francis CM, Caruana L, Sutherland GR, McMurray JJ. Assessing diagnosis in heart failure: which features are any use? QJM. 1997;90(5):335-9.
19. Wang CS, Fitzgerald JM, Schulzer M, Mak E, Ayas NT. Does this dyspneic patient in the emergency department have congestive heart failure? JAMA. 2005;294(15):1944-56.
20. Leatham A. Phonocardiography. Brit Med Bull. 1952;8:333.
21. Lewis RP, Rittgers SE, Forester WF, Boudoulas H. A critical review of the systolic time intervals. Circulation. 1977;56:146.
22. Weissler AM, Harris WS, Schoenfield CD. Bedside technics for the evaluation of ventricular function in man. Am J Cardiol. 1969;23:577.
23. Stack RS, Sohn YH, Weissler AM. Accuracy of systolic time intervals in detecting abnormal left ventricular performance in coronary artery disease. Am J Cardiol. 1981;47:603-9.
24. Weissler AM, Harris HS, Schoenfeld CD. Systolic time intervals in heart failure in man. Circulation. 1968;37:149-59.
25. Garrard CL, Weissler AM, Dodge HT. The relationship of alterations in systolic time intervals to ejection fraction in patients with cardiac disease. Circulation. 1970;62:455-62.
26. Weissler AM, Peeler RG, Roehll WH. Relationships between left ventricular ejection time, stroke volume, and heart rate in normal individuals and patients with cardiovascular disease. Am Heart J. 1961;62:367-78.
27. Roos M, Toggweiler S, Jamshidi P, Zuber M, Kobza R, Meier, R, et al. Non-invasive Detection of Left-Ventricular Systolic Dysfunction by Acoustic Cardiography in Cardiac Failure Patients. J Card Fail. 2008;14(4):310-9.
28. Jamshidi P, Roos M, Kobza R, Toggweiler S, Zuber M, Erne P. Impact of Preload Changes on Positive and Negative Left-ventricular dP/dt and Systolic Time Intervals. Submitted for publication.
29. Siegel, W, Lim JS, Proudfit WL, Sheldon WC, M.D, Loop FD. The spectrum of exercise test and angiographic correlations in myocardial revascularization surgery. Circulation. 1975; 52(2 Suppl):1156-62.
30. Thompson PL. Physical Examination in ischaemic heart disease. Med J Aust. 1976;1(14):492-5.
31. Perez GL, Luisada AA. When does a fourth sound become an atrial gallop? Angiology. 1976;27(5):300-10.
32. Upton MT. Detecting abnormalities in left ventricular function during exercise before angina and ST-segment depression. Circulation. 1980;62(2)341-9.
33. Ishikawa M, Sakata K; Maki A, Mizuno H, Ishikawa K. Prognostic significance of a clearly audible fourth heart sound detected a month after an acute myocardial infarction. Am J Cardiol. 1997;80(5):619-21.
34. Gerber IL, McKeown BH, Marcus G, Vessy J, Jordan MV, Huddleston M, et al. The third and fourth heart sounds are highly specific markers for elevated left ventricular filling pressure and reduced ejection fraction. J Card Fail. 2004;10(4):S36.
35. Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, Huddleston M, et al. Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA. 2005;293(18):2238-44.
36. Peacock WF, Harrison A. The utility of heart sounds and systolic intervals across the care continuum. CHF. 2006;(4 Supple 1):2-7.
37. Shah SJ, Michaels AD. Haemodynamic correlates of the third heart sound and systolic time intervals. CHF 2006;12(4 Supple 1):8-13.
38. Roos M, Toggweiler S, Zuber M, Jamshidi P, Erne P. Acoustic Cardiographic Parameters and their Relationship to Invasive Haemodynamic Measurements in Patients with Left Ventricular Systolic Dysfunction. CHF. 2006;12(4 Supple 1):19-24.
39. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly. 2007;137(1-2):4-12.
40. Zuber M, Kipfer P, Attenhofer-Jost Ch. Usefulness of Acoustic Cardiography to Resolve Ambiguous Values of B-Type Natriuretic Peptide Levels in Patients With Suspected Heart Failure. Am J Cardiol. 2007;100(5): 866-9.
41. Moyers B, Shapiro M, Marcus GM, Gerber IL, McKeown BH, Vessey JC, et al. The Performance of Phonoelectrocardiographic Left Ventricular Systolic Time Intervals and B-type Natriuretic Peptide Levels in the Diagnosis of Left Ventricular Dysfunction. Ann Noninvasive Electrocardiol. 2007;12(2):89-97.
42. Lainscak M, Keber I. Heart failure clinic in a community hospital improves outcome in heart failure patients. Swiss Med Wkly. 2006;136(17-18):274- 80.
43. Collins SP, Lindsell CJ, Peacock WF, Hedger VD, Eckert DC, Askew J, et al. The Combined Utility of an S3 Heart Sound and B-type Natriuretic Peptide Levels in Emergency Department Patients with Dyspnea. J Cardiac Fail. 2006;12(4):286-92.
44. Collins SP, Lindsell CJ, Peacock WF, Hedger VD, Storrow AB. The Effect of Treatment on the Presence of Abnormal Heart Sounds in Emergency Department Patients with Heart Failure. Am J Emerg Med. 2006;24:25-32.
45. Maisel A, Peacock WF, Clopton P, Daniels L, Collins S. The Presence of an S3 is Associated with an Increased Rate of Adverse Cardiac Events. J Cardiac Fail. 2007;13(6):143.
46. Zuber M, Attenhofer-Jost Ch, Kipfer P, Collins S, Michota F, Peacock F. Acoustic Cardiography Augments Prolonged QRS Duration for Detecting Left Ventricular Dysfunction. Ann Noninvasive Electrocardiol. 2007;12(4):316-28.
47. Zuber M, Kipfer P, Attenhofer Jost Ch, Erne P. Utility of Acoustic Cardiography to Improve the Diagnosis of Acute Coronary Syndrome. Personal communication.
48. Harris I, Lee E, Yeghiazarians Y, Drew BJ, Michaels AD. Phonocardiographic Timing of Third and Fourth Heart Sounds during Acute Myocardial Infarction. J Electrocardiology. 2006;39:305-9.
49. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AG, Jani D, et al. Prevalence of rheumatic heart disease detected by echocardiography screening. N Engl J Med. 2007;357:470-6.
50. Yetman A, McCrindle B, Freedom R, Gow R. Myocardial bridging in children with hypertrophic cardiomyopathy - a risk factor for sudden death. N Engl J Med. 1998;339:1201-9.
51. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. Int J Cardiol. 2006;106:21-8.
52. Mutlu GM, Rubinstein I. Obstructive Sleep Apnoea Syndrome-Associated Nocturnal Myocardial Ischemia Chest. 2000;117:1534-5.
53. Thurnheer R. Obstructive sleep apnoea and cardiovascular disease - time to act! Swiss Med Wkly. 2007;137(15-16):217-22.
54. Isenhour JL, Craig S, Gibbs M, Littman L, Rose G, Risch R. Wide-complex tachycardia - continued evaluation of diagnostic criteria. Acad Emerg Med. 2000;7:769-73.
55. Kolettis TM, Kyriakides ZS, Popov T, Mesiskli T, Papalambrou A, Kremastinos DT. Importance of the site of ventricular tachycardia origin on left ventricular hemodynamics in humans. Pacing Clin Electrophysiol. 1999;22:871-9.
56. Garratt CJ, Griffith MJ, Young G, Curzen N, Brecker S, Rickards AF, et al. Value of physical signs in the diagnosis of ventricular tachycardia. Circulation. 1994;90:3103-7.
57. Kobza R, Roos M, Toggweiler S, Zuber M, Erne P. Recorded Heart Sounds for Identification of Ventricular Tachycardia. Submitted for publication.
58. Toggweiler S, Zuber M, Kobza R, Roos M, Jamshidi P, Maier R, et al. Improved Response to Cardiac Resynchronization Therapy Through Optimization of Atrioventricular and Interventricular Delays Using Acoustic Cardiography: A Pilot Study. J Card Fail. 2007;13(8):637-42.
59. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873-80.
60. Sticherling C, Schaer B, Coenen M, Kühne M, Ammann P, Osswald S. Cardiac resynchronization therapy in chronic heart failure. Swiss Med Wkly. 2006;136(39-40):611-7.
61. Hasan A, Abraham WT, Quinn-Tate L, Brown L, Amkieh A. Optimization of Cardiac Resynchronization Devices Using Acoustic Cardiography: a Comparison to Echocardiography. Congest Heart Fail. 2006;12(4 suppl 1):25-31.
62. Zuber M, Toggweiler S, Roos M, Kobza R, Jamshidi P, Erne P. Comparison of Different Approaches for Optimization of Atrioventricular and Interventricular Delay in Biventricular Pacing. Europace. 2008;10:367-73.
63. Zuber M, Toggweiler S, Quinn-Tate L, Brown L, Amkieh A, Erne P. A Comparison of Acoustic Cardiography and Doppler Echocardiography for Optimizing Pacemaker Settings in Cardiac Resynchronization Therapy. Submitted for publication.
64. Kontos M, Haney A, et al. Are Systolic Time Intervals Superior to QRS Duration for Detection of LV Dyssynchrony? J Card Fail. 2007;13(6):173.
65. Corbisiero R, Wjasow C, et al. Impact of Intra-Operative CS Lead Placement and Post-Operative AV Optimization on Systolic Function in CRT Patients as Measured by Acoustic Cardiography. J Card Fail. 2007;13(6):133.
66. Toggweiler S, Kobza R, Roos M, Erne P. Visualizing Pacemaker-Induced Phrenic Nerve Stimulation with Acoustic Cardiography. Pacing Clin Electrophysiol. 2007;30:806. 2007.
67. Zuber M, Roos M, Kobza R, Toggweiler S, Meier M, Erne P. Detection and Haemodynamic Significance of Cardiac Pacemaker-Induced Phrenic Nerve Stimulation. Submitted for publication.
68. Navia J, McCarthy PM, Hoercher KJ, Smedira NG, Banbury MK, Blackstone EH. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg. 2002;74:2051-63.
69. Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;doi:10.1093/eur-heartj/ehn020
70. Soroff HS, Hui JCK, Giron F. Historical Review of the Development of Enhanced External Counterpulsation Technology and its Physiologic Rationale. Cardiovasc Rev Reports. 1997;18(11):34-6, 39.
71. Roos M, Zuber M, Bauer P, Erne P. Improved Cardiac Performance Through Pacemaker-Induced Phrenic Nerve Stimulation - A Novel Electrophysiological Approach in Heart Failure Management? Personal communication.
72. Efstratiadis S, Warner RA, Kontos MC, Zuber M, Arand P, Michaels AD. Acoustic cardiographic electromechanical activation time correlates with echocardiographic parameters of left ventricular contractility in patients with myocardial ischemia. International Society for Computerized Electrocardiography Scientific Sessions. J Electrocardiol. 2008, in Press.
73. Warner RA, Arand PA. An Improved Screening Test for Left Ventricular Systolic Dysfunction. International Society for Computerized Electrocardiography Scientific Sessions, J Electrocardiol. 2008, in Press.
74. Naqvi TZ, Bauer P, Castillo E, Innes T, Manzoor B, Zhang J, Wheeler T. Insight into Cardiac Hemodyamics Using A Novel Ambulatory Monitoring Device in a Patient with CHF and Sleep Apnea. Personal Communication.